Australia's Federal Court recently decided that gene patenting is permitted in Australia, yet in the USA, "a landmark ruling by the US Supreme Court in June 2012 declared that naturally occurring DNA sequences were ineligible for patents in a case that involved the same breast cancer gene, and the same patent holder." This is despite there being an estimated 4,000 gene patents in the United States!
Rodney Scott, Professor of Genetics at University of Newcastle, Australia states that:
1. Genetic patents hinder, or don’t foster, innovation.
2. Patents have traditionally been granted for isolated genes rather than for any kind of innovation.
3. Gene patents for tests create monopolies that lead to high prices.
4. Monopolies lead to a lack of quality assurance.
Full article :